{"id":51442,"date":"2023-09-20T09:21:39","date_gmt":"2023-09-20T09:21:39","guid":{"rendered":"https:\/\/medsname.com\/arkamin\/"},"modified":"2026-09-12T04:33:28","modified_gmt":"2026-09-12T04:33:28","slug":"arkamin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/arkamin\/","title":{"rendered":"Arkamin"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin: 0 0 8px 0; font-size: 16px; font-weight: bold;\">\u26a1 Quick Answer \u2014 What is Arkamin?<\/h3>\n<p style=\"margin: 0;\"><strong>Arkamin<\/strong> este un <strong>Comprimat de Clonidin\u0103 100 mcg<\/strong> from Torrent Pharma \u2014 a <strong>agonist alfa-2 adrenergic cu ac\u021biune central\u0103 (imidazolinic) care reduce fluxul simpatic<\/strong>, ac\u021bion\u00e2nd asupra <strong>receptorilor alfa-2 adrenergici pre-sinaptici (\u0219i receptorilor imidazolinici-1) din medulla rostral\u0103 ventrolateral\u0103<\/strong>. Clonidina a fost introdus\u0103 de Boehringer Ingelheim \u00een 1966 sub denumirea <strong>Catapres<\/strong>. Sintetizat\u0103 ini\u021bial ca decongestionant nazal, o observa\u021bie accidental\u0103 de hipotensiune profund\u0103 la un voluntar din studiu a condus la reprofilarea sa ca antihipertensiv. Utilizarea modern\u0103 cuprinde hipertensiunea (linia a patra \u0219i urgen\u021be hipertensive), <strong>ADHD<\/strong> (aprobat de FDA \u00een SUA sub denumirea Kapvay ER), <strong>sevraj de opioide \u0219i nicotin\u0103<\/strong>, simptome vasomotorii menopauzale, sindromul Tourette, adjuvan\u021bi pentru durere (intratecal) \u0219i premedica\u021bie anestezic\u0103. Timp de \u00eenjum\u0103t\u0103\u021bire 12-16 ore (oral); 20-24 ore (plasture transdermic); debut 30-60 minute (oral); concentra\u021bie plasmatic\u0103 maxim\u0103 1-3 ore; efect antihipertensiv 2-4 ore; durat\u0103 8-12 ore. Indica\u021bii principale: <strong>hipertensiune rezistent\u0103 sau de linia a patra, urgen\u021b\u0103 hipertensiv\u0103 (oral\/sublingual), ADHD, sevraj de opioide\/nicotin\u0103, soflete menopauzale, adjuvan\u021bi pentru durere \u0219i anestezie<\/strong>. Dozaj tipic: <strong>Hipertensiune cronic\u0103:<\/strong> 100 mcg (0,1 mg) de dou\u0103 sau trei ori pe zi, titr\u00e2nd p\u00e2n\u0103 la un maxim obi\u0219nuit de 800 mcg\/zi. <strong>Nu este un antihipertensiv de prim\u0103 linie<\/strong> \u2014 reserve for fourth\/fifth-line after ACEi\/ARB, CCB, thiazide, and spironolactone. <strong>Urgen\u021b\u0103 hipertensiv\u0103 (oral):<\/strong> 100-200 mcg loading dose, then 100 mcg every hour up to 600 mcg; lowers BP by 10-20% within 1-2 hours. Not for hypertensive emergency (end-organ damage) \u2014 use IV agents. <strong>Nu opri\u021bi brusc Arkamin<\/strong> \u2014 rebound hypertension is severe and potentially life-threatening. For most hypertensive patients, modern treatment starts with an ACE inhibitor\/ARB, a calcium-channel blocker, a thiazide, and spironolactone before reaching for an alpha-blocker or centrally-acting agent.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate \u00een \u00eentreaga lume \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 nume de medicament pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesator reglementat (descrierile de pe extrasul de cont includ un procesator de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau nume de medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este acoperit\u0103 de Politica noastr\u0103 de Asigurare pentru Retrimitere.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Arkamin?<\/h2>\n<p>Arkamin este un comprimat oral de 100 mcg de Clonidin\u0103 de la Torrent Pharma, furnizat \u00een cutii de 30-90 de comprimate. Clonidina a fost introdus\u0103 de Boehringer Ingelheim \u00een 1966 ca <strong>Catapres<\/strong>. Sintetizat\u0103 ini\u021bial ca decongestionant nazal, o observa\u021bie accidental\u0103 de hipotensiune profund\u0103 la un voluntar din studiu a condus la reprofilarea sa ca antihipertensiv. Utilizarea modern\u0103 cuprinde hipertensiunea (linia a patra \u0219i urgen\u021be hipertensive), <strong>ADHD<\/strong> (aprobat de FDA \u00een SUA sub denumirea Kapvay ER), <strong>sevraj de opioide \u0219i nicotin\u0103<\/strong>, simptome vasomotor menopauzale, sindrom Tourette, adjuvant de durere (intratecal) \u0219i premedica\u021bie anestezic\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Cum ac\u021bioneaz\u0103 Clonidina<\/h2>\n<p>Clonidina ac\u021bioneaz\u0103 pe <strong>receptorilor alfa-2 adrenergici pre-sinaptici (\u0219i receptorilor imidazolinici-1) din medulla rostral\u0103 ventrolateral\u0103<\/strong>. Efectele secundare:<\/p>\n<ul>\n<li><strong>Reducerea debitului simpatic central<\/strong> \u2014 activation of pre-synaptic alpha-2 receptors in the rostral ventrolateral medulla suppresses descending sympathetic tone to the peripheral vasculature and heart<\/li>\n<li><strong>Sc\u0103derea noradrenalinei plasmatice<\/strong> \u2014 circulating catecholamines fall 30-50% within hours; heart rate drops 5-15 bpm; BP drops 10-30 mmHg<\/li>\n<li><strong>Activitatea receptorului Imidazolin\u0103-1<\/strong> \u2014 an additional sympathetic-suppressing mechanism unique to imidazoline agonists (clonidine, moxonidine); may contribute to better metabolic tolerability than older centrally-acting drugs<\/li>\n<li><strong>Ac\u021biune analgezic\u0103 spinal\u0103 \u0219i supraspinal\u0103<\/strong> \u2014 blocks pain signal relay in the dorsal horn; basis for intrathecal clonidine in chronic pain and for anaesthetic-adjunct use<\/li>\n<li><strong>Suprimarea simptomelor de sevraj noradrenergic<\/strong> \u2014 reduces sweating, tremor, tachycardia, and hypertension during opioid, nicotine, and alcohol withdrawal<\/li>\n<li><strong>\u00cembun\u0103t\u0103\u021birea tonusului cortical prefrontal<\/strong> \u2014 proposed mechanism for ADHD benefit (enhances top-down inhibitory control)<\/li>\n<li><strong>Ac\u021biune anti-termoregulatorie central\u0103<\/strong> \u2014 basis for menopausal hot-flush benefit<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri aprobate \u0219i bazate pe dovezi<\/h2>\n<ul>\n<li><strong>Hipertensiune rezistent\u0103 sau de linia a patra, urgen\u021b\u0103 hipertensiv\u0103 (oral\/sublingual), ADHD, sevraj opioid\/nicotinic, sofleuri menopauzale, adjunct \u00een durere \u0219i anestezie<\/strong><\/li>\n<li><strong>Hipertensiune rezistent\u0103<\/strong> (linia a patra\/a cincea)<\/li>\n<li><strong>Urgen\u021b\u0103 hipertensiv\u0103<\/strong> (oral 100-200 mcg loading, then 100 mcg hourly) \u2014 not for emergency with end-organ damage<\/li>\n<li><strong>ADHD<\/strong> (aprobat de FDA sub forma cu eliberare prelungit\u0103 Kapvay; formul\u0103ri cu eliberare imediat\u0103 utilizate off-label la nivel global)<\/li>\n<li><strong>Sevraj opioid \u0219i nicotin\u0103<\/strong> \u2014 autonomic symptom relief<\/li>\n<li><strong>Simptome vasomotorii menopauzale (furnic\u0103turi \u0219i transpira\u021bii nocturne)<\/strong> \u2014 non-hormonal option<\/li>\n<li><strong>Sindromul Tourette<\/strong> \u0219i tulbur\u0103ri de tic<\/li>\n<li><strong>Durere cronic\u0103<\/strong> \u2014 intrathecal clonidine for neuropathic or cancer pain<\/li>\n<li><strong>Premedica\u021bie anestezic\u0103 \u0219i tremur\u0103turi perioperatorii<\/strong><\/li>\n<\/ul>\n<p><strong>Dovezile din studiile pivotale:<\/strong> <strong>Studiul Cooperativ VA privind Hipertensiunea (1967-1970)<\/strong> \u2014 clonidine established as effective monotherapy in the era before ACEi, ARB, and CCB classes. <strong>Analizele subgrupului ALLHAT<\/strong> \u2014 clonidine-based regimens generally reduced BP equivalently to first-line classes but with worse tolerability. <strong>Studiile pediatrice ADHD Connor et al.<\/strong> \u2014 clonidine IR effective for hyperarousal and sleep disturbance in ADHD, though psychostimulants remain first-line. <strong>Gold et al. (1978)<\/strong> \u2014 landmark demonstration of clonidine for opiate withdrawal \u2014 abolished autonomic symptoms (sweating, piloerection, tachycardia) without cross-dependence.<\/p>\n<h2 class=\"wp-block-heading\">Doza Arkamin<\/h2>\n<p><strong>Doza primar\u0103:<\/strong> <strong>Hipertensiune cronic\u0103:<\/strong> 100 mcg (0,1 mg) de dou\u0103 sau trei ori pe zi, titr\u00e2nd p\u00e2n\u0103 la un maxim obi\u0219nuit de 800 mcg\/zi. <strong>Nu este un antihipertensiv de prim\u0103 linie<\/strong> \u2014 reserve for fourth\/fifth-line after ACEi\/ARB, CCB, thiazide, and spironolactone. <strong>Urgen\u021b\u0103 hipertensiv\u0103 (oral):<\/strong> 100-200 mcg loading dose, then 100 mcg every hour up to 600 mcg; lowers BP by 10-20% within 1-2 hours. Not for hypertensive emergency (end-organ damage) \u2014 use IV agents.<\/p>\n<p><strong>Alte indica\u021bii:<\/strong> <strong>ADHD (copii \u0219i adolescen\u021bi):<\/strong> 50-100 mcg la ora de culcare ini\u021bial, titr\u00e2nd p\u00e2n\u0103 la 100-400 mcg\/zi \u00een doze divizate. Formulele cu eliberare prelungit\u0103 (Kapvay) sunt preferate \u00een SUA. <strong>Sevraj opioid (aliniere simptome autonome):<\/strong> 100-300 mcg de trei sau patru ori pe zi, cu reducere progresiv\u0103 pe m\u0103sur\u0103 ce sevrajul se rezolv\u0103. <strong>V\u0103rs\u0103turi menopauzale:<\/strong> 50-75 mcg de dou\u0103 ori pe zi. <strong>Sindromul Tourette:<\/strong> 25-100 mcg de dou\u0103 sau trei ori pe zi. <strong>\u00cencetarea fumatului:<\/strong> 100-300 mcg\/zi (oral sau transdermal). <strong>Premedica\u021bie anestezic\u0103:<\/strong> 200-400 mcg oral cu 60 de minute \u00eenainte de opera\u021bie.<\/p>\n<p><strong>Administrare:<\/strong> se poate lua cu sau f\u0103r\u0103 m\u00e2ncare; dozele de sear\u0103 sunt mai mari dec\u00e2t cele de zi pentru a transfera efectul sedativ \u00een somn. Nu rata\u021bi dozele (risc de rebound).<\/p>\n<p><strong>Program de monitorizare:<\/strong><\/p>\n<ul>\n<li><strong>Valori ini\u021biale:<\/strong> tensiune arterial\u0103 \u00een decubit \u0219i ortostatism (documenta\u021bi sc\u0103derea postural\u0103), frecven\u021b\u0103 cardiac\u0103, ECG (screening pentru bradicardie), lista de medicamente (verifica\u021bi interac\u021biuni).<\/li>\n<li><strong>S\u0103pt\u0103m\u00e2na 1-2:<\/strong> repetare tensiune arterial\u0103 (decubit \u0219i ortostatism), frecven\u021b\u0103 cardiac\u0103, evaluare simptome. Ajusta\u021bi doza \u00een func\u021bie de tensiune \u0219i tolerabilitate.<\/li>\n<li><strong>S\u0103pt\u0103m\u00e2na 4-6:<\/strong> evalua\u021bi TA \u021bint\u0103; povara simptomatologic\u0103; \u00eentreba\u021bi \u00een mod specific despre dozele omise.<\/li>\n<li><strong>Continuu:<\/strong> revedere anual\u0103 a TA \u0219i cardiac\u0103; nu epuiza\u021bi niciodat\u0103 stocul (risc de hipertensiune de rebound).<\/li>\n<li><strong>\u00centrerupe\u021bi sau reduce\u021bi doza la:<\/strong> bradicardie sever\u0103, sincop\u0103, bloc AV de gradul doi sau trei, depresie major\u0103, sedare deranjant\u0103 care nu se \u00eembun\u0103t\u0103\u021be\u0219te la 4-8 s\u0103pt\u0103m\u00e2ni.<\/li>\n<\/ul>\n<p><strong>\u00centrerupere:<\/strong> <strong>CRITICAL \u2014 never stop clonidine abruptly.<\/strong> Hipertensiunea de rebound cu cre\u0219terea activit\u0103\u021bii simpatice poate ap\u0103rea \u00een 18-36 de ore la doze &gt;300 mcg\/zi. <strong>Reduce\u021bi progresiv pe parcursul a 2-4 s\u0103pt\u0103m\u00e2ni<\/strong>; dac\u0103 este prescris concomitent un beta-blocant, \u00eentrerupe\u021bi mai \u00eent\u00e2i beta-blocantul \u0219i apoi clonidina. C\u0103uta\u021bi \u00eengrijiri medicale urgente pentru cefalee sever\u0103, durere toracic\u0103 sau TA &gt;180\/110 dup\u0103 doze omise sau \u00eentrerupte.<\/p>\n<h2 class=\"wp-block-heading\">Considera\u021bii practice pentru Arkamin<\/h2>\n<ul>\n<li><strong>Rebound hypertension on abrupt discontinuation \u2014 CRITICAL, potentially life-threatening.<\/strong> Dozele omise sau \u00eentreruperea brusc\u0103 pot provoca o cre\u0219tere a activit\u0103\u021bii simpatice \u00een 18-36 de ore: cre\u0219tere a TA cu 30-50 mmHg, tahicardie, transpira\u021bie, tremur \u0219i rapoarte rare de accident vascular cerebral, infarct miocardic \u0219i encefalopatie hipertensiv\u0103. <strong>Reduce\u021bi treptat doza de clonidin\u0103 pe o perioad\u0103 de 2-4 s\u0103pt\u0103m\u00e2ni<\/strong> mai degrab\u0103 dec\u00e2t s\u0103 fie \u00eentrerupt brusc. Riscul este cel mai mare la doze &gt;300 mcg\/zi \u0219i \u00een combina\u021bie cu beta-blocante.<\/li>\n<li><strong>Patch transdermic<\/strong> (Catapres TTS, 100\/200\/300 mcg per day patches applied weekly) gives smoother plasma levels and mitigates rebound risk \u2014 useful for patients with adherence issues.<\/li>\n<li><strong>Sedare \u0219i gur\u0103 uscat\u0103<\/strong> sunt aproape universale la \u00eenceput; de obicei se atenueaz\u0103 par\u021bial \u00een 2-4 s\u0103pt\u0103m\u00e2ni. Lua\u021bi doza principal\u0103 la ora de culcare pentru a transfera sedarea \u00een somn.<\/li>\n<li><strong>Precau\u021bie la terapia combinat\u0103 cu beta-blocante<\/strong> \u2014 if discontinuing, stop the beta-blocker first, then taper clonidine several days later; reverse order can cause especially severe rebound because the beta-blocker blocks the compensatory reflexes.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente (&gt;1%):<\/strong><\/p>\n<ul>\n<li><strong>Sedare, somnolen\u021b\u0103<\/strong> (foarte frecvente, mai ales \u00een primele 2-4 s\u0103pt\u0103m\u00e2ni)<\/li>\n<li><strong>Gur\u0103 uscat\u0103<\/strong> (foarte frecvent)<\/li>\n<li><strong>Ame\u021beli, hipotensiune ortostatic\u0103<\/strong><\/li>\n<li><strong>Constipa\u021bie<\/strong><\/li>\n<li><strong>Disfunc\u021bie erectil\u0103 \u0219i libido redus<\/strong><\/li>\n<li><strong>Depresie, modific\u0103ri de stare<\/strong><\/li>\n<li><strong>Bradicardie, bloc cardiac<\/strong> (\u00een special cu terapie concomitent\u0103 cu beta-blocante sau digoxin)<\/li>\n<li><strong>Cre\u0219terea \u00een greutate, reten\u021bie de sodiu<\/strong> pe parcursul lunilor<\/li>\n<li><strong>Reac\u021bii cutanate la plasturele transdermic<\/strong> (dermatit\u0103 de contact 10-50%)<\/li>\n<li><strong>Tulbur\u0103ri de somn, vise vii, co\u0219maruri<\/strong><\/li>\n<\/ul>\n<p><strong>Pu\u021bin frecvente, dar clinic importante:<\/strong><\/p>\n<ul>\n<li><strong>Criz\u0103 hipertensiv\u0103 de rebond<\/strong> on abrupt discontinuation \u2014 stroke, MI, hypertensive encephalopathy reported.<\/li>\n<li><strong>Bradicardie sever\u0103 \u0219i bloc atrioventricular<\/strong>, \u00een special cu terapie concomitent\u0103 cu beta-blocante, digoxin\u0103 sau CCB nedihidropiridinice (verapamil, diltiazem).<\/li>\n<li><strong>Sedare profund\u0103<\/strong> interfering with work or driving \u2014 dose-limiting in some patients.<\/li>\n<li><strong>Depresie<\/strong> sau agravarea depresiei preexistente.<\/li>\n<li><strong>Disfunc\u021bie nod sinusal, sincop\u0103<\/strong>.<\/li>\n<li><strong>Dermatit\u0103 de contact alergic\u0103 sever\u0103 cu plasture transdermic<\/strong> \u2014 rotate sites; stop if severe.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii<\/h2>\n<ul>\n<li>Hipersensibilitate cunoscut\u0103 la clonidin\u0103<\/li>\n<li>Bradiaritmie sever\u0103, sindromul sinusului bolnav, bloc AV de gradul doi sau trei f\u0103r\u0103 stimulator cardiac<\/li>\n<li>Depresie sever\u0103 (relativ\u0103)<\/li>\n<li>Concurrent use of other central alpha-2 agonists (methyldopa, tizanidine) \u2014 additive hypotension and sedation<\/li>\n<li>Sarcin\u0103: de obicei evitat\u0103 (se prefer\u0103 metildop\u0103 sau labetalol); datele sunt limitate, nu este clar teratogen\u0103, dar experien\u021ba este mult mai mare cu alternativele<\/li>\n<li>Al\u0103ptare: trece semnificativ \u00een laptele matern<\/li>\n<\/ul>\n<p><strong>Sarcina:<\/strong> generally avoided as first-choice \u2014 methyldopa and labetalol have larger safety databases. Clonidine is not clearly teratogenic and is sometimes used as add-on therapy in resistant gestational hypertension.<\/p>\n<p><strong>Al\u0103ptarea:<\/strong> significant transfer to breast milk \u2014 monitor the infant for sedation, bradycardia, and poor feeding; consider alternative agents.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Beta-blockers \u2014 CRITICAL.<\/strong> Terapia combinat\u0103 agraveaz\u0103 hipertensiunea de rebond la \u00eentreruperea clonidinei. Dac\u0103 ambele medicamente sunt \u00eentrerupte simultan, \u00eentrerupe\u021bi mai \u00eent\u00e2i beta-blocantul c\u00e2teva zile, apoi reduce\u021bi treptat clonidina. Beta-blocantele cresc, de asemenea, riscul de bradicardie atunci c\u00e2nd sunt combinate cu clonidina.<\/li>\n<li><strong>Digoxin\u0103, CCB-uri nedihidropiridinice (verapamil, diltiazem)<\/strong> \u2014 additive bradycardia and AV block.<\/li>\n<li><strong>Antidepresive triciclice \u0219i alfa-antagoni\u0219ti<\/strong> \u2014 partially antagonise clonidine\u2019s antihypertensive effect; may require higher clonidine doses.<\/li>\n<li><strong>Depresante ale SNC (opioide, benzodiazepine, alcool, gabapentinoide)<\/strong> \u2014 sedare aditiv\u0103.<\/li>\n<li><strong>Alte antihipertensive cu ac\u021biune central\u0103 (metildopa, tizanidin\u0103, moxonidin\u0103)<\/strong> \u2014 additive sedation and hypotension; usually not combined.<\/li>\n<li><strong>Mirtazapin\u0103<\/strong> \u2014 alpha-2 antagonism reduces clonidine effect.<\/li>\n<li><strong>Diuretice<\/strong> \u2014 synergistic BP-lowering; standard combination in resistant HTN.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Pozi\u021bionarea Arkamin \u00een ierarhia antihipertensivelor<\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 14px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Nivel<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Clas\u0103 \/ Exemple<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Rol<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Prima linie<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Inhibitori ACE (<a href=\"https:\/\/medsbase.com\/ro\/ramcor\/\">ramipril<\/a>), BRA (<a href=\"https:\/\/medsbase.com\/ro\/telmaheal\/\">telmisartan<\/a>), BCC (<a href=\"https:\/\/medsbase.com\/ro\/amlode\/\">amlodipine<\/a>), tiazide (<a href=\"https:\/\/medsbase.com\/ro\/natrilix-sr\/\">indapamide<\/a>, HCTZ)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pornire tratament pentru HTA nou diagnosticat\u0103<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Agent secundar\/ter\u021biar<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Combina\u021bii ale celor de mai sus (IECA+BCC, BRA+tiazid\u0103)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">C\u00e2nd un singur agent este insuficient<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Al patrulea agent (HTA rezistent\u0103)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/aldactone\/\">Spironolacton\u0103<\/a> (dovad\u0103 PATHWAY-2); beta-blocant; doxazosin\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dac\u0103 TA r\u0103m\u00e2ne necontrolat\u0103 pe o combina\u021bie de trei medicamente la doz\u0103 maxim\u0103<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Al cincilea agent<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Alfa-blocante<\/strong> (<a href=\"https:\/\/medsbase.com\/ro\/prazopress\/\">prazosin\u0103<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/hytrin\/\">terazosin<\/a>, doxazosin); agen\u021bi cu ac\u021biune central\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ad\u0103uga\u021bi dac\u0103 spironolactonul este inadecvat sau contraindicated; prefera\u021bi alfa-blocante acolo unde coexist\u0103 HBP<\/td>\n<\/tr>\n<tr style=\"background: #fff3cd;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Al cincilea \/ al \u0219aselea agent<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Agen\u021bi cu ac\u021biune central\u0103<\/strong> (<a href=\"https:\/\/medsbase.com\/ro\/arkamin\/\">clonidin\u0103<\/a>, moxonidin\u0103)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ad\u0103uga\u021bi pentru a aduce hipertensiunea rezistent\u0103 la \u021bint\u0103; monitoriza\u021bi reboundul \u0219i sedarea<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Linie de prim\u0103 inten\u021bie \u00een sarcin\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong><a href=\"https:\/\/medsbase.com\/ro\/alphadopa\/\">Metildop\u0103<\/a><\/strong>, <a href=\"https:\/\/medsbase.com\/ro\/labebet\/\">labetalol<\/a>, nifedipin\u0103<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Hipertensiunea gesta\u021bional\u0103 \u0219i hipertensiunea preexistent\u0103 \u00een timpul sarcinii<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>Store Arkamin below 25\u00b0C in the original blister pack. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">De ce este at\u00e2t de periculos s\u0103 omite\u021bi dozele de Arkamin?<\/h3>\n<p>Clonidine suppresses central sympathetic outflow. When clonidine levels fall abruptly, the stored sympathetic drive &#8220;rebounds&#8221; within 18-36 hours \u2014 BP surges 30-50 mmHg, heart rate rises, and the patient sweats, tremors, and develops severe headache. Case reports describe rebound stroke, myocardial infarction, and hypertensive encephalopathy. This risk is greatest at doses above 300 mcg\/day and with concurrent beta-blockade. <strong>Nu opri\u021bi niciodat\u0103 clonidina brusc<\/strong> \u2014 taper over 2-4 weeks under medical supervision. Always order repeat supply 1-2 weeks before running out.<\/p>\n<h3 class=\"wp-block-heading\">O s\u0103 m\u0103 fac\u0103 Arkamin somnoros?<\/h3>\n<p>Yes \u2014 sedation and daytime somnolence are the most common complaints, affecting up to half of patients in the first 2-4 weeks. It usually improves substantially by week 4-6. Strategies: shift more of the daily dose to bedtime so sedation occurs during sleep; avoid alcohol and other CNS depressants; do not drive or operate machinery until you know how Arkamin affects you. If sedation remains unacceptable after 6-8 weeks, switch to an alternative (moxonidine, methyldopa in pregnancy only, or a different antihypertensive class).<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 iau Arkamin cu alcool?<\/h3>\n<p>Light, occasional drinking is usually tolerated. Regular or heavy drinking substantially potentiates the orthostatic hypotension and sedation of Arkamin \u2014 falls, blackouts, and accidents become more likely. Patients at higher risk (elderly, previous falls, concurrent diuretics or sedatives) should avoid alcohol altogether on this medication.<\/p>\n<h3 class=\"wp-block-heading\">Poate fi utilizat Arkamin pentru ADHD?<\/h3>\n<p>Yes \u2014 clonidine is FDA-approved in the United States as extended-release <strong>Kapvay<\/strong> for ADHD in children and adolescents, and is used off-label (as immediate-release) internationally. It is not first-line (psychostimulants \u2014 methylphenidate, amphetamines \u2014 give larger mean effect sizes on core ADHD symptoms), but clonidine has a specific niche in hyperarousal, sleep onset, tics, and stimulant-side-effect management. Typical paediatric dose: 50-100 mcg at bedtime initially, titrating to 100-400 mcg\/day in divided doses under specialist supervision.<\/p>\n<h3 class=\"wp-block-heading\">Ce fac dac\u0103 uit o doz\u0103?<\/h3>\n<p><strong>Lua\u021bi doza ratat\u0103 imediat ce v\u0103 aminti\u021bi<\/strong>, even if it is close to the next scheduled dose \u2014 clonidine\u2019s rebound-hypertension risk means that missed doses must be replaced promptly. If you realise within 6 hours, take the missed dose and continue as normal. If more than 12 hours have passed and rebound symptoms (severe headache, palpitations, sweating) are emerging, take the dose and seek urgent medical review. Never let your supply run out \u2014 order repeat prescriptions 1-2 weeks before the current stock is exhausted.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 opresc Arkamin dac\u0103 tensiunea mea este sub control?<\/h3>\n<p><strong>Nu brusc.<\/strong> Hipertensiunea de rebond \u00een 18-36 de ore dup\u0103 oprirea clonidinei poate precipita accident vascular cerebral, infarct miocardic sau encefalopatie hipertensiv\u0103. Reduce\u021bi progresiv doza pe parcursul a 2-4 s\u0103pt\u0103m\u00e2ni sub supraveghere medical\u0103. Dac\u0103 lua\u021bi un beta-blocant, opri\u021bi mai \u00eent\u00e2i beta-blocantul, apoi reduce\u021bi clonidina c\u00e2teva zile mai t\u00e2rziu.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 iau Arkamin \u00een timpul sarcinii?<\/h3>\n<p>Generally no. Pregnancy antihypertensives of choice are methyldopa, labetalol, and nifedipine \u2014 Arkamin is not first-line in pregnancy. Switch to one of those before conception or as soon as pregnancy is confirmed, under specialist supervision.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Arkamin online?<\/h3>\n<p>Pute\u021bi cump\u0103ra Arkamin (100 mcg clonidin\u0103, 30-90 comprimate) de la MedsBase cu ambalaj discret \u0219i livrare la nivel mondial.<\/p>\n<h2 class=\"wp-block-heading\">Antihipertensive \u00eenrudite pe MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/aldactone\/\">Aldactone \u2014 Spironolactone 25\/50\/100 mg (PATHWAY-2 4th-line)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/alphadopa\/\">Alphadopa \u2014 Methyldopa 250 mg (pregnancy-safe HTN)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/hytrin\/\">Hytrin \u2014 Terazosin 1\/2\/5 mg (AbbVie)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/minipress-xl\/\">Minipress XL \u2014 Prazosin ER 2.5\/5 mg (Pfizer)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ramcor\/\">Ramcor \u2014 Ramipril 2.5\/5\/10 mg (ACEi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/telma-h\/\">Telma H \u2014 Telmisartan + HCTZ combination<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-blood-pressure-medication\/\"><strong>R\u0103sfoi\u021bi toate medicamentele pentru hipertensiune arterial\u0103<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background: #fff3f3; border-left: 4px solid #d9534f; padding: 16px 20px; margin: 24px 0; border-radius: 4px;\"><strong>\u2695 Medical Disclaimer.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Hypertension, heart failure, and arrhythmias require diagnosis, monitoring, and dose individualisation by a doctor \u2014 always use beta-blockers under medical guidance.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/robinax\/\">Robinax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/affexor-xr\/\">Affexor XR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/xyzal\/\">Xyzal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/duolin-inhaler\/\">Duolin Inhalator<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/noltrexate\/\">Noltrexate<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Arkamin este clonidina 100 mcg de la Torrent Pharma \u2014 agonistul original alfa-2 adrenergic cu ac\u021biune central\u0103 (Catapres al lui Boehringer Ingelheim, 1966). Reduce debitul simpatic central; scade noradrenalina periferic\u0103 cu 30-50%. Utiliz\u0103ri: hipertensiune de linia a patra\/cincea, urgen\u021b\u0103 hipertensiv\u0103, ADHD (aprobat de FDA ca Kapvay XR \u00een SUA), sevraj de opioide \u0219i nicotin\u0103, soflete menopauzale, sindromul Tourette, adjunct anestezic. CRITIC \u2014 nu \u00eenceta\u021bi brusc (risc de hipertensiune de rebound cu accident vascular cerebral, infarct miocardic).<\/p>","protected":false},"featured_media":51443,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3357,3358],"class_list":{"0":"post-51442","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-arkamin","11":"product_tag-clonidine","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/51442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=51442"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/51443"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=51442"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=51442"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=51442"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=51442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}